After Hours Summary: DOCU -16.9%, ZUMZ -16.6%, RIVN -13.2%, AOUT -11.9% fall on earnings; ORCL bounces back after initial fall following earnings; LAZY +20.3% higher on acquisition proposalAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: ALTO +15.1%, LOCO +6.7% (also names new CEO), NAPA +3.6%, ULTA +1.4% (also authorizes a new $2.0 bln share repurchase program), MLNK +0.2% (also to acquire StreetShares), ORCL +0.2%
Companies trading higher in after hours in reaction to news: LAZY +20.3% (RILY proposes to acquire LAZY for $25/sh; also discloses 8.6% stake in LAZY), MAPS +4% (names new chairman), IRNT +0.4% (stock offering)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: TLYS -21.6%, DOCU -16.9% (also authorizes up to $200 mln for share repurchases), ZUMZ -16.6%, AVO -14.1%, RIVN -13.2%, AOUT -11.9% (also announces acquisition of Grilla Grills), SHLS -7.3% (also announces opening of new manufacturing facility), ISPO -6.9%, BLNK -6.3%, WPM -1.1%
Companies trading lower in after hours in reaction to news: SQNS -10.3% (launches public offering of ADSs), AGNC -0.5% (announces estimated tangible net book value of $13.48/sh), FDX -0.3% (CEO to retire, names new CEO), PTON -0.3% (hires Chief Supply Chain Officer), AMK -0.1% (reports company highlights for February)
Research Calls
- Upgrades:
- Alpha Metallurgical Resources (AMR) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $155
- Arista Networks (ANET) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $160
- CrowdStrike (CRWD) upgraded to Buy from Neutral at BTIG Research; tgt $257
- Essential Utilities (WTRG) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $53
- Givaudan SA (GVDNY) upgraded to Hold from Sell at Societe Generale
- Hormel Foods (HRL) upgraded to Buy from Hold at Argus; tgt $57
- IDEAYA Biosciences (IDYA) upgraded to Buy from Hold at Stifel; tgt lowered to $20
- KB Home (KBH) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $51
- NetApp (NTAP) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $102
- Pilgrim's Pride (PPC) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $30
- Toll Brothers (TOL) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $58
- Downgrades:
- Asana (ASAN) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $32
- Cisco (CSCO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $65
- Coterra Energy (CTRA) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $26
- Green Brick Partners (GRBK) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $20
- Hess Midstream Partners (HESM) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $33
- Huntington Ingalls (HII) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $215
- McDonald's (MCD) downgraded to Neutral from Buy at Northcoast
- Meritage (MTH) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $111
- Mettler-Toledo (MTD) downgraded to Sell from Neutral at Goldman; tgt $1240
- Pfizer (PFE) upgraded to Buy from Neutral at Independent Research; tgt $54
- SLR Capital Partners (SLRC) downgraded to Neutral from Buy at Compass Point; tgt $20
- Walt Disney (DIS) downgraded to Neutral from Overweight at Atlantic Equities; tgt lowered to $172
- Others:
- Avista (AVA) initiated with a Neutral at Mizuho; tgt $47
- C4 Therapeutics (CCCC) initiated with an Overweight at JP Morgan; tgt $43
- Canadian Nat'l Rail (CNI) resumed with a Neutral at JP Morgan
- Canadian Pacific (CP) resumed with an Overweight at JP Morgan, added to U.S. Analyst Focus List
- Eli Lilly (LLY) initiated with an Outperform at Daiwa Securities; tgt $286
- Esperion Therapeutics (ESPR) initiated with a Buy at H.C. Wainwright; tgt $22
- Franklin BSP Realty Trust (FBRT) resumed with a Mkt Outperform at JMP Securities; tgt $15
- Hims & Hers Health (HIMS) initiated with a Hold at Deutsche Bank; tgt $7
- IdaCorp (IDA) initiated with a Buy at Mizuho; tgt $119
- Kymera Therapeutics (KYMR) initiated with a Neutral at JP Morgan; tgt $44
- NorthWestern (NWE) initiated with a Neutral at Mizuho; tgt $62
- Verrica Pharmaceuticals (VRCA) initiated with a Buy at Brookline; tgt $20